Oxygenta Pharmaceutical Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.00",
    "chg": 0.37,
    "chgp": "0.65%",
    "dir": 1,
    "prev_price": "56.63",
    "mcapval": "218.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE102E01018",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "8.84 k",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3949152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_mojoScore_3949152.png",
        "date": "2026-04-16 10:10:16",
        "description": "Oxygenta Pharmaceutical Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3933253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_mojoScore_3933253.png",
        "date": "2026-04-05 10:10:11",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-falls-to-52-week-low-of-rs453-3928529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_priceRelatedfactors_3928529.png",
        "date": "2026-04-01 09:59:54",
        "description": ""
      },
      {
        "title": "Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3924463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3924463.png",
        "date": "2026-03-30 11:19:08",
        "description": ""
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3909790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_mojoScore_3909790.png",
        "date": "2026-03-24 10:10:16",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3886687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_mojoScore_3886687.png",
        "date": "2026-03-12 10:10:18",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869473.png",
        "date": "2026-03-04 11:28:43",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869475.png",
        "date": "2026-03-04 11:28:34",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3862142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3862142.png",
        "date": "2026-02-28 10:10:14",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 226,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Compliance As Per Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended 31St March 2026",
      "datetime": "15-Apr-2026",
      "details": "Compliance as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Closure of Trading Window for the period ending on 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "20-Feb-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Discloure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-04-16 10:10:16

Oxygenta Pharmaceutical Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-04-05 10:10:11

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-01 09:59:54

Read full news article

Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 11:19:08

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-03-24 10:10:16

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-03-12 10:10:18

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:43

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months.

Read full news article

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:34

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-28 10:10:14

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News